Repeated oral administration of oleanolic acid produces cholestatic liver injury in mice

Molecules

Volumn 18, Issue 3, 2013, Pages 3060-3071

  Lu, Yuan Fu ^a   Wan, Xiao Li ^a   Xu, Yasha ^a   Liu, Jie ^a,b  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Bile acid synthesis; Bile acid transporters; Cholestasis; Inflammation; Oleanolic acid; Oral administration

Indexed keywords

ACUTE PHASE PROTEIN; BILE ACID; BIOLOGICAL MARKER; OLEANOLIC ACID; ORGANIC ANION TRANSPORTER 1;

ANIMAL; ARTICLE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHOLESTASIS; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; LIVER; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PATHOLOGY;

ACUTE-PHASE PROTEINS; ADMINISTRATION, ORAL; ANIMALS; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; BODY WEIGHT; CHOLESTASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INFLAMMATION; LIVER; MALE; MICE; OLEANOLIC ACID; ORGAN SIZE; ORGANIC ANION TRANSPORT PROTEIN 1;

EID: 84875634706     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18033060     Document Type: Article

References (30)

1. Liu, J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 1995, 49, 57-68.
2. Pollier, J.; Goossens, A. Oleanolic acid. Phytochemistry 2012, 77, 10-15.
3. Sultana, N.; Ata, A. Oleanolic acid and related derivatives as medicinally important compounds. J. Enzyme Inhib. Med. Chem. 2008, 23, 739-756.
4. Petronelli, A.; Pannitteri, G.; Testa, U. Triterpenoids as new promising anticancer drugs. Anticancer Drugs 2009, 20, 880-892.
5. Wang, X.; Li, Y.L.; Wu, H.; Liu, J.Z.; Hu, J.X.; Liao, N.; Peng, J.; Cao, P.P.; Liang, X.; Hai, C.X. Antidiabetic effect of oleanolic acid: A promising use of a traditional pharmacological agent. Phytother Res. 2011, 25, 1031-1040.
6. Liu, J. Oleanolic acid and ursolic acid: Research perspectives. J. Ethnopharmacol. 2005, 100, 92-94.
7. Kinjo, J.; Okawa, M.; Udayama, M.; Sohno, Y.; Hirakawa, T.; Shii, Y.; Nohara, T. Hepatoprotective and hepatotoxic actions of oleanolic acid-type triterpenoidal glucuronides on rat primary hepatocyte cultures. Chem. Pharm. Bull. (Tokyo) 1999, 47, 290-292.
8. Sato, H.; Genet, C.; Strehle, A.; Thomas, C.; Lobstein, A.; Wagner, A.; Mioskowski, C.; Auwerx, J.; Saladin, R. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem. Biophys. Res. Commun. 2007, 362, 793-798.
9. Sharma, S.; Sharma, O.P.; Dawra, R.K.; Bhat, T.K. Disposition of lantadene A, the pentacyclic triterpenoid hepatotoxin, orally administered to guinea pigs. Toxicol. Lett. 1999, 105, 59-66.
10. Milkiewicz, P.; Heathcote, J. Cholestasis induced by Chinese herbal remedy Xia-Ku-Hua-Tan-Pian. Liver Int. 2011, 31, 746-747.
11. Zoja, C.; Corna, D.; Nava, V.; Locatelli, M.; Abbate, M.; Gaspari, F.; Carrara, F.; Sangalli, F.; Remuzzi, G.; Benigni, A. Analogues of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects. Am. J. Physiol. Renal Physiol. 2012, doi:10.1152/ajprenal.00376.2012.
12. Liu, J.; Liu, Y.; Mao, Q.; Klaassen, C.D. The effects of 10 triterpenoid compounds on experimental liver injury in mice. Fundam. Appl. Toxicol. 1994, 22, 34-40.
13. Copple, B.L.; Jaeschke, H.; Klaassen, C.D. Oxidative stress and the pathogenesis of cholestasis. Semin. Liver Dis. 2010, 30, 195-204.
14. Woolbright, B.L.; Jaeschke, H. Novel insight into mechanisms of cholestatic liver injury. World J. Gastroenterol. 2012, 18, 4985-4993.
15. Brambila, E.; Munoz-Sanchez, J.L.; Waalkes, M.P.; Albores, A. Effect of surgically induced cholestasis on the levels of hepatic zinc and metallothionein in rat liver. Biol. Trace Elem. Res. 2000, 78, 255-264.
16. Froh, M.; Conzelmann, L.; Walbrun, P.; Netter, S.; Wiest, R.; Wheeler, M.D.; Lehnert, M.; Uesugi, T.; Scholmerich, J.; Thurman, R.G. Heme oxygenase-1 overexpression increases liver injury after bile duct ligation in rats. World J. Gastroenterol. 2007, 13, 3478-3486.
17. Aleksunes, L.M.; Slitt, A.L.; Maher, J.M.; Dieter, M.Z.; Knight, T.R.; Goedken, M.; Cherrington, N.J.; Chan, J.Y.; Klaassen, C.D.; Manautou, J.E. Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis. Cell Stress Chaperones 2006, 11, 356-363.
18. Chiang, J.Y. Bile acids: Regulation of synthesis. J. Lipid Res. 2009, 50, 1955-1966.
19. Csanaky, I.L.; Lu, H.; Zhang, Y.; Ogura, K.; Choudhuri, S.; Klaassen, C.D. Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice. Hepatology 2011, 53, 272-281.
20. Lam, P.; Soroka, C.J.; Boyer, J.L. The bile salt export pump: Clinical and experimental aspects of genetic and acquired cholestatic liver disease. Semin. Liver Dis. 2010, 30,125-133.
21. Lu, H.; Choudhuri, S.; Ogura, K.; Csanaky, I.L.; Lei, X.; Cheng, X.; Song, P.Z.; Klaassen, C.D. Characterization of organic anion transporting polypeptide 1b2-null mice: Essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. Toxicol. Sci. 2008, 103, 35-45.
22. Liu, J.; Lu, Y.F.; Zhang, Y.C.; Wu, C.; Klaassen, C.D. Oleanolic acid produces cholestatic liver injury in C57 mice. Toxicologist 2013, 132, A1087.
23. Xi, J.; Tang, H.; Zheng, Y. Oral dosage forms of oleanolic acid and their pharmacokinetics. Chin. J. New Drugs 2009, 18, 507-515.
24. Wang, J.B.; Zhao, H.P.; Zhao, Y.L.; Jin, C.; Liu, D.J.; Kong, W.J.; Fang, F.; Zhang, L.; Wang, H.J.; Xiao, X.H. Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury. PLoS One 2011, 6, e24498.
25. Chitturi, S.; Farrell, G.C. Herbal hepatotoxicity: An expanding but poorly defined problem. J. Gastroen. Hepatol. 2000, 15, 1093-1099.
26. Teschke, R.; Frenzel, C.; Schulze, J.; Eickhoff, A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained? Regul. Toxicol. Pharmacol. 2012, 63, 1-9.
27. Li, M.K.; Crawford, J.M. The pathology of cholestasis. Semin. Liver Dis. 2004, 24, 21-42.
28. Hagenbuch, B.; Gui, C. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 2008, 38, 778-801.
29. Klaassen, C.D.; Aleksunes, L.M. Xenobiotic, bile acid, and cholesterol transporters: Function and regulation. Pharmacol. Rev. 2010, 62, 1-96.
30. Boyer, J.L.; Trauner, M.; Mennone, A.; Soroka, C.J.; Cai, S.Y.; Moustafa, T.; Zollner, G.; Lee, J.Y.; Ballatori, N. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha- OSTbeta in cholestasis in humans and rodents. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G1124-G1130.